Navigation Links
Regulatory Leader in OASIS Documentation Introduces OASIS-C Products
Date:10/12/2009

DES MOINES, Iowa, Oct. 12 /PRNewswire/ -- Briggs, a leading provider of solutions to improve clinical outcomes and reduce operating costs in the home care market, today announced new OASIS-C products to meet extensive regulatory changes mandated by the Centers for Medicare & Medicaid Services (CMS).

The new OASIS-C products include Briggs' proprietary documentation for all OASIS assessment forms as well as a new online training course to support the regulatory changes.

The OASIS-C assessment enables home health care providers to capture more data while reducing the chance for errors and omissions in patient documentation. In addition to affecting the patients' program of care, errors and omissions can impact an agency's regulatory compliance, delay or minimize reimbursements and increase operating costs.

"Briggs' OASIS-C assessments include proprietary information to address three key areas: addressing problems before they become serious, treating existing conditions as efficiently as possible and intervention prior to re-hospitalization," says Sharon Hamilton, RN, BAB, CNLCP, CFDS, Briggs' Clinical Consultant-Home Care. "Unlike other assessments, Briggs provides the safeguards agencies need to stay compliant and maximize reimbursements."

Briggs backs up its new OASIS-C documentation with an online training course, accessible to home care clinicians through their computer. The 7-hour, 11 section course covers all the CMS changes, uses interactive modules to fully engage participants and offers pre- and post-testing features to help gauge improving proficiency.

In developing the OASIS-C products, Briggs has built on its core competencies as the regulatory leader in OASIS documentation. According to an independent study conducted by OCS, Inc., home care agencies using Briggs' OASIS forms report better outcomes for all CMS measurements, lower occurrence rates, reduced resource utilization and reduce
'/>"/>

SOURCE Briggs
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. EpiCept Reports Regulatory Progress on Ceplene(TM)
2. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
3. Anesiva Defines Regulatory Pathway for Adlea with FDA
4. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
5. EpiCept Provides Update on Clinical and Regulatory Progress with Ceplene(TM) and EpiCept(TM) NP-1 Cream
6. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
7. Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
8. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
9. PulmoBioTech Announces Details of Its Regulatory Approval Experiments
10. Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
11. XTENT Announces European Regulatory Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... VIEW, Calif. , Aug. 31, 2015 /PRNewswire/ ... for flow cytometry is experiencing a rise in ... the demand in underdeveloped nations to quantitate CD4 ... Logo - http://photos.prnewswire.com/prnh/20150831/262206LOGO ... Analysis of the Global Flow Cytometry Market ( ...
(Date:8/31/2015)... HARRISBURG, Pa. , Aug. 31, 2015 ... been reversed statewide since Pennsylvania ... the life-saving drug kits, naloxone. Heroin and ... in Pennsylvania , killing more individuals ... 2013, approximately 2,400 Pennsylvanians died from a drug overdose. ...
(Date:8/31/2015)... , Aug. 31, 2015  The departments of ... event today at Gaudenzia Concept 90 to raise awareness ... overdose crisis in Pennsylvania and ... and focus on recovery through the Building Bridges ... Pennsylvanians are dying every day to a disease that ...
Breaking Medicine Technology:Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2
... Phase 1 Colorectal and Prostate Cancer,Trials To Be ... FRANCISCO, Calif., May 23, 2007 /PRNewswire-FirstCall/,-- Poniard Pharmaceuticals, ... announced that data from a Phase 2 trial,of ... small cell lung cancer (SCLC) will be presented ...
... Urine Flow, With,Long Lasting Effect in Phase 2 ... Spectrum,Pharmaceuticals, Inc., today announced Phase 2 safety and ... the treatment,of benign prostatic hypertrophy (BPH), at the ... Convention Center in,Anaheim, California on Tuesday, May 22, ...
Cached Medicine Technology:Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 2Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 3Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 2Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 3Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 5
(Date:9/1/2015)... ... September 01, 2015 , ... USA ... informational video this week to coincide with back-to-school and the start of “sick ... to the CDC, elementary school children are sick an average of 8 to ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... Self-Directed Care is, how to access caregivers and what to look for and ... and pertinent information. , Founded in 2006 in Canoga Park, CA by CEO, ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... archiving solution integrated with Alfresco‘s enterprise content management system. PRO Archiver for ... millions of dollars in printing costs by digitizing vast amounts of customer ...
(Date:9/1/2015)... ... , ... Elizabeth Callahan, MD, founder and medical director of SkinSmart Dermatology® ... RADIESSE® filler treatment for volume loss in the hands. RADIESSE provides an immediate volumizing ... hands, delivering smooth, natural-looking results that can last up to one year in most ...
(Date:9/1/2015)... ... 01, 2015 , ... A new episode of “Voices In America”, hosted by ... the topic of arthritis. There are over 100 different types of arthritis. One of ... statistics in an effort to shed light on this important topic. , Anyone who ...
Breaking Medicine News(10 mins):Health News:USA Medical Card Launches New FAQ Video During Back-to-School 2Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 2Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 3Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3
... found that low blood cholestrol may stimulate impulsive and ... harming themselves.// A team from St Vincent's Hospital, Dublin, ... injuries, including drug overdoses, with psychiatric patients and patients ... ,The patients were rated on their level of depression, ...
... benefit from investing in gymnasium membership and a exercise personal ... Cleavland University // it is better to exercise at home ... machines are often advertised in a misleading way. For instance, ... body, and you may need to learn certain skills - ...
... get prostate cancer than men with other blood groups, despite ... affects your health.// In particular, men with blood group A ... and to get more aggressive forms of the disease. Hence ... type A, but not confirmed as yet. ,Researchers at ...
... for visually- impaired patients.Retinal cell transplants can restore vision ... them. Researchers at the University of Texas, have transplanted ... to blindness.// Experiments showed that the rats were then ... normal vision. ,This is an important step ...
... day life. According to researchers drinking coffee stops the decline ... the morning hours, memory is at its best in ... University of Arizona have found that coffee can find ... about 60-70 participants aged over 64 do a verbal learning ...
... A research has found that if women drink too much ... developing epileptic seizures or fits.//Studies have found that caffeine may ... from newborn mammals that have been briefly starved of oxygen. ... Santé in France examined cells from the hippocampus, a part ...
Cached Medicine News:
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: